
    
      The study subjects must have moderate psoriasis of the body and scalp with an ISGA of 3 at
      baseline. In addition, the subjects must have an evaluable target lesion of at least 2 cmÂ² on
      the body with a score of 2 or 3 for erythema, scaling and plaque. All subjects will apply
      Calcipotriene Foam, 0.005% or vehicle foam topically twice a day (am and pm) to all psoriatic
      lesions on the body and scalp. Study visits will occur at baseline (day 1) and at weeks 1, 2,
      4, and 8.
    
  